ConductScience.org, home

Paper6352005

A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.

Løber J and 5 others. Cancer, 1983. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer. Papers, record 6352005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6352005

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
PubMed
Journal
Cancer
PubMed
Year
1983
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.92
iCite
Revised in PubMed
2019-06-20
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Løber JJ
2Mouridsen HTH T
3Christiansen IEI E
4Dombernowsky PP
5Mattsson WW
6Rørth MM

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Breast NeoplasmsMajor topic
ChlorambucilMajor topic
PrednimustineMajor topic
Adult
Aged
Clinical Trials as Topic
Drug Therapy, Combination
Female
Hallucinations
Hematologic Diseases
Humans
Middle Aged
Nausea
Prednisolone
Random Allocation

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
8164452Continuous versus intermittent prednimustine treatment of non-Hodgkin's lymphoma.Med Oncol Tumor Pharmacother1993https://conductscience.org/library/papers/8164452PubMed
6871484Prednimustine in combination with methotrexate and 5-fluorouracil in advanced breast cancer: a phase I-II study.Breast Cancer Res Treat1983https://conductscience.org/library/papers/6871484PubMed
3948307Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3948307PubMed
3568275Treatment of refractory chronic lymphocytic leukemia with prednimustine: a phase II study using strict response criteria.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3568275PubMed
3170130Mitoxantrone in combination with prednimustine in treatment of unfavorable non-Hodgkin lymphoma.Invest New Drugs1988https://conductscience.org/library/papers/3170130PubMed
2924378Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2924378PubMed
2491962Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2491962PubMed
2013118Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/2013118PubMed
1914086Mitozantrone and prednimustine in the treatment of advanced breast cancer--a toxic regimen with low activity.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/1914086PubMed
1537076Cellular kinetics of prednimustine versus chlorambucil plus prednisolone in vitro.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1537076PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6352005

GET https://conductscience.org/api/papers/v1/6352005/authors